Burcon NutraScience Corporation
BU.TO · TSX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | CA$0 | CA$1 | CA$1 | CA$5 |
| - Cash | CA$0 | CA$0 | CA$0 | CA$0 |
| + Debt | CA$0 | CA$0 | CA$0 | CA$0 |
| Enterprise Value | CA$0 | CA$1 | CA$1 | CA$5 |
| Revenue | CA$0 | CA$0 | CA$0 | CA$0 |
| % Growth | 106.9% | -49.3% | 112.2% | – |
| Gross Profit | -CA$0 | CA$0 | CA$0 | CA$0 |
| % Margin | -228.3% | 100% | 100% | 100% |
| EBITDA | -CA$0 | -CA$0 | -CA$0 | -CA$0 |
| % Margin | -1,949.3% | -3,380% | -5,194.7% | -5,787.8% |
| Net Income | -CA$0 | -CA$0 | -CA$0 | -CA$0 |
| % Margin | -2,167% | -4,039% | -6,969.9% | -5,982.6% |
| EPS Diluted | -1.06 | -0.031 | -0.11 | -0.047 |
| % Growth | -3,364.1% | 72.2% | -133.1% | – |
| Operating Cash Flow | -CA$0 | -CA$0 | -CA$0 | -CA$0 |
| Capital Expenditures | -CA$0 | -CA$0 | -CA$0 | -CA$0 |
| Free Cash Flow | -CA$0 | -CA$0 | -CA$0 | -CA$0 |